Advanced bladder cancers respond to immunotherapy regardless of gene mutation status

(UNC Lineberger Comprehensive Cancer Center) UNC Lineberger researchers and colleagues report a study has demonstrated that patients with advanced bladder cancers whose tumors have a mutated FGFR3 gene respond to immunotherapy in a manner that is similar to patients without that mutation. This discovery runs counter to previous research that suggested FGFR3-mutated bladder cancers should not be treated with immunotherapy.

https://www.eurekalert.org/pub_releases/2021-07/ulcc-abc072221.php

Source: EurekAlert! - Cancer - July 22, 2021 Category: Cancer & Oncology Source Type: news